🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Metformin (part 1)

Found 70 matching trials

A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS

PHASE4

We hypothesized that a portion controlled diet would prevent the weight gai...

Status

Completed

Location

Pennington Center

Start Date

2003-02

Trial ID

NCT00219440

Treatments Being Tested

Actos plus standard diet Actos plus structured diet Metformin plus standard diet

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01 Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg, and to Evaluate the Effect of Food on the Pharmacokinetics of DA-1229_01 in Healthy Male Volunteers

PHASE1

This Phase I clinical study is to evaluate the safety/tolerability and phar...

Status

Completed

Location

Clinical Trial Center, Seoul National University Hospital

Start Date

2014-07

Trial ID

NCT02167061

Treatments Being Tested

DA-1229_01 E+M DA-1229_01 fast DA-1229_01 fed

TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus

PHASE1

This is a phase 1, randomized, double-blind, placebo-controlled, 2-center, ...

Status

Completed

Location

Multiple Locations

Start Date

2015-04

Trial ID

NCT02430870

Treatments Being Tested

TAK-648 Placebo

Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine

PHASE1

This study will investigate the potential drug interactions between vemirco...

Status

Completed

Location

Research Site

Start Date

2024-01-17

Trial ID

NCT06071442

Treatments Being Tested

Vemircopan Rosuvastatin Metformin Levonorgestrel / Ethinyl Estradiol Carbamazepine

Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes

Type 2 diabetic patients who fast during Ramadan experience swings in glyca...

Status

Completed

Location

Endocrinology Unit & Diabetes Management Centre, Services Hospital.

Start Date

2011-08

Trial ID

NCT01624116

Treatments Being Tested

Acarbose Diet and lifestyle Metformin Metformin/ Glimepride Metformin/Sitagliptin

The Interaction Between Metformin and Microbiota - the MEMO Study.

N/A

Metformin has been used in Sweden since 1957, and it is recommended as firs...

Status

Unknown

Location

Region Västerbotten

Start Date

2019-02-20

Trial ID

NCT03718715

Treatments Being Tested

Metformin

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

PHASE1

The aim of this study is to assess the effect of coadministration of multip...

Status

Completed

Location

Local Institution - 0001

Start Date

2022-11-11

Trial ID

NCT05615012

Treatments Being Tested

BMS-986322 Rosuvastatin Metformin Glucose Methotrexate Leucovorin

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

N/A

The study investigators are interested in learning more about how drugs, th...

Status

Recruiting

Location

Phoenix Children's Hospital

Start Date

2020-03-05

Trial ID

NCT04278404

Treatments Being Tested

The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

PHASE2

This study is the first administration of GSK2890457 in humans. The study w...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-02-10

Trial ID

NCT01725126

Treatments Being Tested

GSK2890457 Metformin Placebo Liraglutide

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers

PHASE1

This is a an open-label, randomized, single dose, four-way crossover, multi...

Status

Terminated

Location

GSK Investigational Site

Start Date

2012-09-27

Trial ID

NCT01725672

Treatments Being Tested

Metformin, 500 mg extended release tablet Metformin, 1000 mg extended release tablet Glimepiride, 1 mg immediate release tablet Glimepiride, 2 mg immediate release tablet Metformin, 500 mg and Glimepiride, 1 mg extended release film coated tablet containing release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release film coated tablet containing release controlling polymers Metformin, 500 mg and Glimepiride, 1 mg extended release tablet coated with release controlling polymers Metformin, 1000 mg and Glimepiride, 2 mg extended release tablet coated with release controlling polymers

Previous Next